It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
First RSV vaccine caps 60-year search to stem pervasive lung illness

World / Science & Health May 4, 2023

First RSV vaccine caps 60-year search to stem pervasive lung illness

by Suzi Ring

The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.

Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments

Business May 1, 2023

Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments

by Rocky Swift

The deal marks the fifth major overseas acquisition by Astellas, Japan's third biggest drugmaker by sales, since 2019.

Mystery middleman may offer clues to Indian-made cough syrup deaths

Asia Pacific Apr 30, 2023

Mystery middleman may offer clues to Indian-made cough syrup deaths

by Krishna N. Das and Jennifer Rigby

The deaths of more than 70 Gambian children from acute kidney Injury were linked by global health officials to cough syrups made in India.

Cancer vaccine hunt makes progress, finally

Commentary / World Apr 21, 2023

Cancer vaccine hunt makes progress, finally

by Lisa Jarvis

A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.

As U.S. Supreme Court pauses abortion pill case, what happens next?

World Apr 20, 2023

As U.S. Supreme Court pauses abortion pill case, what happens next?

by Brendan Pierson

A lower court order imposing significant restrictions on the distribution of the abortion drug mifepristone stems from a lawsuit brought by anti-abortion groups seeking to ban the pill.

Abortion pill rulings to impact pharmaceutical innovation

Commentary / World Apr 19, 2023

Abortion pill rulings to impact pharmaceutical innovation

by Lisa Jarvis

Bringing new drugs to market is already expensive and time-consuming. Undercutting the FDA will only make it harder.

Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer

World / Science & Health Apr 17, 2023

Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer

The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer's return.

Schizophrenia drug may offer much-needed progress

Commentary / World Apr 12, 2023

Schizophrenia drug may offer much-needed progress

by Lisa Jarvis

Late-stage data on a treatment in development by Karuna Therapeutics for schizophrenia show promise on sharply reducing harsh side effects.

U.S. judge hands anti-abortion groups partial win in abortion pill challenge

World Apr 8, 2023

U.S. judge hands anti-abortion groups partial win in abortion pill challenge

The ruling said the challenge is substantially likely to succeed, with the justice saying that the U.S. Food and Drug Administration had ignored risks in approving the drug mifepristone.

Just how dangerous are India’s generic drugs? Very.

Commentary / World Apr 5, 2023

Just how dangerous are India’s generic drugs? Very.

by Ruth Pollard

The red flags for Indian drugs have been there for years. The world deserves much better than contaminated medicine and children poisoned by cough syrup.

Xanax and Adderall access is being blocked by secret drug limits in U.S.

World / Science & Health Apr 4, 2023

Xanax and Adderall access is being blocked by secret drug limits in U.S.

by Ike Swetlitz

Patients diagnosed with conditions like anxiety and sleep disorders have become caught in the crosshairs of America’s opioid crisis.

Japan’s COVID vaccine orders lacked solid estimate of demand, watchdog says

National Mar 30, 2023

Japan’s COVID vaccine orders lacked solid estimate of demand, watchdog says

by Tomoko Otake

The health ministry failed to show enough grounds for its decision to procure a total of 882 million vaccine doses for the government-funded vaccination drive, the Board of Audit said.

« 1 2 3 4 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times